|
Market Closed -
Euronext Dublin
11:55:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 6.950 EUR | 0.00% |
|
-0.71% | -9.74% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 30.13M 33.8M 27.91M 25.38M 47.62M 3.2B 48.4M 335M 132M 1.67B 127M 124M 5.35B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.23M 19.33M 15.96M 14.51M 27.23M 1.83B 27.68M 191M 75.27M 958M 72.52M 71M 3.06B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -0.71% | ||
| Current month | -0.71% | ||
| 1 month | +2.21% | ||
| 3 months | -3.47% | ||
| 6 months | -13.12% | ||
| Current year | -9.74% |
| 1 week | 6.95 |  | 6.95 |
| 1 month | 6.8 | | 7 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 13.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/26 | Exercice | 10,307 | 0.2382% | |||
| 5/28/25 | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.71% | -19.65% | +61.63% | 33.89M | |
| -1.33% | +4.88% | +53.33% | +109.94% | 1,120B | |
| -0.69% | -3.77% | +31.01% | +66.62% | 616B | |
| -0.96% | +0.55% | +21.81% | +94.26% | 504B | |
| +0.24% | +6.23% | +33.98% | +52.38% | 367B | |
| -1.59% | -1.25% | +66.39% | +43.02% | 360B | |
| -0.40% | +4.28% | +19.17% | +42.51% | 288B | |
| -0.37% | +3.11% | -1.31% | +18.23% | 258B | |
| -1.75% | +1.76% | +40.09% | +51.44% | 234B | |
| -2.00% | +1.75% | +24.34% | +95.14% | 194B | |
| Average | -0.61% | +2.91% | +26.92% | +63.52% | 394.09B | |
| Weighted average by Cap. | -0.61% | +3.52% | +36.92% | +74.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.74M -6.39M -5.81M -10.91M -734M -11.08M -76.66M -30.15M -384M -29.04M -28.43M -1.23B |
| Net Debt | -62.1M -69.67M -57.53M -52.3M -98.15M -6.6B -99.76M -690M -271M -3.45B -261M -256M -11.04B | -12.9M -14.47M -11.95M -10.87M -20.39M -1.37B -20.72M -143M -56.36M -717M -54.3M -53.16M -2.29B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | €6.950 | 0.00% | 0 |
| 26-10-16 | €6.950 | 0.00% | 0 |
| 26-10-15 | €6.950 | 0.00% | 1,050 |
| 26-10-14 | €6.950 | 0.00% | 36 |
| 26-10-13 | €6.950 | 0.00% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.950EUR
Average target price
15.50EUR
Spread / Average Target
+123.02%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
